.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
Daiichi Sankyo
McKesson
Baxter
Citi
Fuji
Boehringer Ingelheim
Mallinckrodt
QuintilesIMS

Generated: November 23, 2017

DrugPatentWatch Database Preview

Latanoprost - Generic Drug Details

« Back to Dashboard

What are the generic sources for latanoprost and what is the scope of latanoprost patent protection?

Latanoprost
is the generic ingredient in two branded drugs marketed by Bausch And Lomb, Amring Pharms, Fdc Ltd, Sandoz Inc, Dr Reddys Labs Ltd, Mylan, Akorn, Apotex Inc, and Pharmacia And Upjohn, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for latanoprost. Fourteen suppliers are listed for this compound. There is one tentative approval for this compound.

Pharmacology for latanoprost

Ingredient-typeProstaglandins
Drug ClassProstaglandin Analog

Tentative approvals for LATANOPROST

Applicant Application No. Strength Dosage Form
u► Subscribe0.005%SOLUTION; OPHTHALMIC
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
LATANOPROST
latanoprost
SOLUTION/DROPS;OPHTHALMIC091449-001Mar 22, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
XALATAN
latanoprost
SOLUTION/DROPS;OPHTHALMIC020597-001Jun 5, 1996ATRXYesYes► Subscribe► Subscribe► Subscribe
Mylan
LATANOPROST
latanoprost
SOLUTION/DROPS;OPHTHALMIC201786-001Mar 22, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Amring Pharms
LATANOPROST
latanoprost
SOLUTION/DROPS;OPHTHALMIC200925-001Mar 22, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Fdc Ltd
LATANOPROST
latanoprost
SOLUTION/DROPS;OPHTHALMIC202442-001Apr 22, 2016ATRXNoNo► Subscribe► Subscribe► Subscribe
Bausch And Lomb
LATANOPROST
latanoprost
SOLUTION/DROPS;OPHTHALMIC201006-001Mar 22, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Akorn
LATANOPROST
latanoprost
SOLUTION/DROPS;OPHTHALMIC090887-001Jul 19, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
LATANOPROST
latanoprost
SOLUTION/DROPS;OPHTHALMIC077697-001Mar 22, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
LATANOPROST
latanoprost
SOLUTION/DROPS;OPHTHALMIC202077-001Feb 11, 2013ATRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: latanoprost

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
XALATAN
latanoprost
SOLUTION/DROPS;OPHTHALMIC020597-001Jun 5, 1996► Subscribe► Subscribe
Pharmacia And Upjohn
XALATAN
latanoprost
SOLUTION/DROPS;OPHTHALMIC020597-001Jun 5, 1996► Subscribe► Subscribe
Pharmacia And Upjohn
XALATAN
latanoprost
SOLUTION/DROPS;OPHTHALMIC020597-001Jun 5, 1996► Subscribe► Subscribe
Pharmacia And Upjohn
XALATAN
latanoprost
SOLUTION/DROPS;OPHTHALMIC020597-001Jun 5, 1996► Subscribe► Subscribe
Pharmacia And Upjohn
XALATAN
latanoprost
SOLUTION/DROPS;OPHTHALMIC020597-001Jun 5, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Merck
McKesson
Daiichi Sankyo
Novartis
McKinsey
Express Scripts
Cipla
Harvard Business School
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot